KureCare has announced the launch of its integrated wound care platform designed to connect patients experiencing non-healing wounds with regenerative treatment providers across the United States. The system addresses treatment access for diabetic foot ulcers, venous leg ulcers, pressure injuries, and slow-healing surgical wounds.
To learn more about the platform and treatment options, go to https://curewounds.com
The platform launch comes as Medicare prepares to implement significant coverage changes for wound care treatments beginning January 1, 2026. The new policy will introduce stricter clinical requirements, including mandatory four-week standard care periods before advanced treatment qualifications and limitations on the number of covered applications per treatment episode.
According to KureCare, their system includes real-time analytics and patient progress tracking accessible through a provider dashboard. It also allows treatment providers to monitor wound healing rates, manage documentation requirements, and access billing templates designed for Medicare compliance.
“Chronic wounds represent a significant healthcare challenge, particularly for patients with diabetes and circulation issues,” stated Kenton Gray, Kure Care’s Founder and CEO. “This platform brings together the clinical tools, compliance support, and patient resources that providers need to deliver advanced wound care.”
For patients, the platform offers an eligibility assessment tool that helps determine Medicare coverage qualification before beginning treatment. Coverage verification typically processes within 24 hours for patients meeting clinical criteria. The system includes a provider locator that shows certified wound care specialists by geographic area.
The treatment approach centers on regenerative biologics applied in outpatient settings with initial patient assessments including wound evaluation and medical history review to develop treatment plans. Follow-up appointments involve monitoring healing progress and adjusting protocols based on response to treatment.
Provider support includes training on biologics application, Medicare billing procedures, and regulatory compliance. The system incorporates documentation templates and pre-authorization checklists designed to meet Medicare requirements for wound care treatments.
The KureCare platform is currently available to healthcare providers and patients nationwide. For more information about eligibility, provider locations, or the platform’s capabilities, visit https://curewounds.com
Kure Care a division of Veracor Group LLC
1150 NW 72ND AVE
TOWER 1 STE 455 #20073
Miami
FL
33126
United States
